Drug Administration Product Applications

On-line Monitoring of Bioprocesses. PTR-MS systems can be used to gather highly relevant process related information in biopharmaceutical fermentations from analyzing volatile metabolites in the fermenters ...

By Ionicon Analytik Ges.m.b.H. based in Innsbruck, AUSTRIA.

Microbe Inotech Laboratories, Inc. provides a microbial genomics platform through licensed database agreements focused on the characterization of microorganisms, pathogens and anti-microbial resistance for pathogen detection, food safety inspections and issues, pharmaceutical discovery, public health surveillance, water and wastewater analysis, agriculture and microbiome analysis and comparisons. From a post-sequencingmetagenomic sample (i.e. DNA extracted from your sample) the MiL Inc. provides identification ...

By Pluton Biosciences, Inc. based in St. Louis, MISSOURI (USA).

From reusable and implantable medical devices to medical tubing, textiles and beyond, Sciessent’s antimicrobial technology can help protect against bacteria growth. ...

By Sciessent LLC based in Beverly, MASSACHUSETTS (USA).

This information is submitted to regulatory agencies, such as the U.S. Food and Drug Administration (FDA), the European Medicines Agency, and Health Canada, to enable approval for patient use. ...

By Zymeworks Inc based in Vancouver, BRITISH COLUMBIA (CANADA).

TrueVue ODM+ enables clinicians to guide fluid and drug administration during major and high-risk surgery. When used to guide perioperative fluid management, ODM is proven to reduce postoperative ...

By Deltex Medical Limited based in Chichester, UNITED KINGDOM.

Since its inception, Yukon Medical has worked directly with clinicians and users to understand their needs and build products that keep them safe and address the complex challenges associated with current devices. The feedback and input of healthcare workers continues to be at the center of everything we do to inform our iterative, human-centered design process, resulting in products built with clinician needs and patient well-being in ...

By Yukon Medical, LLC based in Durham,, NORTH CAROLINA (USA).

Finch’s lead candidate, CP101, is in late-stage clinical development for the prevention of recurrent C. difficile infection (CDI), and has received Breakthrough Therapy and Fast Track designations from the U.S. Food and Drug Administration. In June 2020, Finch announced that CP101 met its primary efficacy endpoint in PRISM3, the first of two pivotal trials to support the development of CP101 for the prevention of recurrent CDI. ...

By Finch Therapeutics Group, Inc. based in Somerville, MASSACHUSETTS (USA).

The pinnacle of scientific evidence is the Level I study. i-FACTOR Bone Graft is one of a small group of bone grafting technologies that is supported by Level I evidence. i-FACTOR Bone Graft was evaluated in a 319-patient, prospective, randomized, controlled, multi-center clinical trial assessing its safety and efficacy compared to standard-of-care (autograft). Patients underwent anterior cervical discectomy and fusion (ACDF) and received either i-FACTOR Bone Graft or local autograft in a cortical allograft ring ...

By Cerapedics, Inc. based in Westminster, COLORADO (USA).